WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Stock Ownership - Who owns Foghorn Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Foghorn Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carlos CostaChief People Officer2024-09-23857$10.17
$8.72kSell
Carlos CostaChief People Officer2024-09-23857$3.72
$3.19kBuy
Carlos CostaChief People Officer2024-09-2035,756$10.04
$358.99kSell
Carlos CostaChief People Officer2024-09-2035,756$3.72
$133.01kBuy
Carlos CostaChief People Officer2024-09-1811,574$10.05
$116.32kSell
Carlos CostaChief People Officer2024-09-1811,574$3.72
$43.06kBuy

1 of 1

FHTX insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FHTX insiders and whales buy or sell their stock.

FHTX Shareholders

What type of owners hold Foghorn Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Flagship Pioneering Inc22.42%12,674,120$63.24MInstitution
Fmr LLC9.79%5,534,516$27.62MInstitution
Bvf Inc9.38%5,302,000$26.46MInstitution
Cigall Kadoch6.41%3,624,379$18.09MInsider
Deerfield Management Company LP5.76%3,255,514$16.25MInstitution
Raymond James Financial Inc4.19%2,367,292$11.81MInstitution
Blackrock Inc3.94%2,229,133$11.12MInstitution
Vanguard Group Inc3.33%1,884,673$9.40MInstitution
Flagship Ventures Fund V General Partner LLC3.28%1,851,801$9.24MInsider
Euclidean Capital LLC2.78%1,573,761$7.85MInstitution

1 of 3

FHTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FHTX72.47%14.12%Net Buying
ALEC59.85%40.15%Net SellingNet Selling
OMER42.72%5.74%
MREO12.39%4.19%
LXEO78.28%13.27%Net BuyingNet Selling
View Top Biotech Stocks

Foghorn Therapeutics Stock Ownership FAQ

Who owns Foghorn Therapeutics?

Foghorn Therapeutics (NASDAQ: FHTX) is owned by 72.47% institutional shareholders, 14.12% Foghorn Therapeutics insiders, and 13.41% retail investors. Cigall Kadoch is the largest individual Foghorn Therapeutics shareholder, owning 3.62M shares representing 6.41% of the company. Cigall Kadoch's Foghorn Therapeutics shares are currently valued at $17.76M.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.